Xi Jin - Concepedia

Author

Xi Jin

Fudan University Shanghai Cancer Center ORCID

Also Known As

Huang, Wei, Jin, Xi, X. Jin, X.Y. Jin, Xi Jin

169

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Fudan University Stanford University West China Hospital of Sichuan University

About

Xi Jin is an author at Fudan University Shanghai Cancer Center specializing in medicine, breast cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	969
2	Natural Sciences	2	2	95
3	Engineering	1	1	19
4	Public Health	1	1	73
5	Biochemistry	1	1	63

Xi Jin

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy Fan Yang, Yi Xiao, Jia-Han Ding, Cell Metabolism	2022	527
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer Hai Wang, Xingyu Rong, Zhao Gan, Cell Metabolism Breast OncologyMedicinePharmacologyBreast CancerAntitumor Immunity	2022	346
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer Yi‐Rong Liu, Yi-Zhou Jiang, Xiao‐En Xu, Breast Cancer Research	2016	213
Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value Yi-Zhou Jiang, Yi‐Rong Liu, Xiao‐En Xu, Cancer Research	2016	189
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation Xi Jin, Xiao‐En Xu, Yi-Zhou Jiang, Science Advances	2019	127
Activation of Extracellular Transglutaminase 2 by Thioredoxin Xi Jin, Cornelius Klöck, Thomas R. DiRaimondo, Journal of Biological Chemistry	2011	113
Molecular classification of hormone receptor-positive HER2-negative breast cancer Xi Jin, Yi-Fan Zhou, Ding Ma, Nature Genetics Breast OncologyPathologyMolecular ClassificationBreast CancerMedicine	2023	97
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer Xi Jin, Li‐Ping Ge, Da‐Qiang Li, Molecular Cancer	2020	87
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer Siyu Wu, Yi Xiao, Jinli Wei, Journal for ImmunoTherapy of Cancer	2021	82
PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer Tian‐Jian Yu, Yingying Liu, Xiaoguang Li, Cancer Research	2021	76

Page 1